01514nam 2200397Ia 450 991069937150332120230902161638.0(CKB)5470000002402199(OCoLC)501180107(EXLCZ)99547000000240219920100121d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] warnings and precautions, contraindications, and boxed warning sections of labeling for human prescription drug and biological products, content and formatRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :Center for Biologics Evaluation and Research,[2006]1 online resource (i, 11 pages)"Draft guidance.""January 2006."Guidance for industry DrugsSide effectsUnited StatesDrugsLabelingUnited StatesBiologicalsLabelingUnited StatesDrugsSide effectsDrugsLabelingBiologicalsLabelingCenter for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910699371503321Guidance for industry3434577UNINA